Detection of Early Idiopathic Pulmonary Fibrosis

Temple University

Status: Active, not recruiting

Conditions: Idiopathic Pulmonary Fibrosis

Treatments: Other: blood samples

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03457935

23201

Details and patient eligibility

About

The purpose of the study is to determine if miR200 family may serve as a biomarker of IPF.

Enrollment: 450 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for IPF Patients:

• Informed consent
• Subjects ≥ 40 y.o.
• Naive patients with no IPF treatment
• IPF diagnosis based on the ATS/ERS/JRS/ALAT criteria

Inclusion Criteria for non-IPF ILD Patients:

• Informed consent
• Subjects ≥ 18 y.o.
• ILD diagnosis

Exclusion Criteria:

• HIV
• Hepatitis B
• Hepatitis C
• Pregnant or lactating women

inclusion criteria for controls: informed consent >18 years old; no lung diseases

Trial design

450 participants in 3 patient groups

Non-IPF ILD

Description:

non-IPF ILD diagnosis

Treatment:

Other: blood samples

IPF

Description:

Naive patients with no IPF treatment

Treatment:

Other: blood samples

Control

Description:

no lung diseases

Treatment:

Other: blood samples